Tag: GLP-1 peptide products

Biocon

Biocon launches formulation for diabetes and obesity

0
Biocon Limited, a global biopharmaceutical company, has announced the launch of its GLP-1 peptide, Liraglutide, for diabetes and obesity, in the United Kingdom (U.K.)....

This function has been disabled for HealthTekPak.

error: Content is protected !!